Phillip Md Et Al Frost Purchases 200,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) Stock
Phillip Md Et Al Frost Purchases 200,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) Stock
OPKO Health, Inc. (NASDAQ:OPK – Get Rating) CEO Phillip Md Et Al Frost bought 200,000 shares of the firm's stock in a transaction dated Thursday, September 15th. The shares were acquired at an average price of $2.06 per share, for a total transaction of $412,000.00. Following the completion of the transaction, the chief executive officer now owns 197,456,694 shares in the company, valued at approximately $406,760,789.64. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
奥普科健康公司(纳斯达克代码：OPK-GET Rating)首席执行官菲利普·马德等·弗罗斯特在9月15日星期四的交易中购买了该公司20万股股票。这些股票是以每股2.06美元的平均价格收购的，总交易额为412,000.00美元。交易完成后，首席执行官现在拥有该公司197,456,694股，价值约406,760,789.64美元。此次收购是在提交给美国证券交易委员会的一份法律文件中披露的，该文件可通过美国证券交易委员会网站访问。
Phillip Md Et Al Frost also recently made the following trade(s):
菲利普·马德和阿尔·弗罗斯特最近还进行了以下交易：
- On Wednesday, August 17th, Phillip Md Et Al Frost bought 200,000 shares of OPKO Health stock. The shares were acquired at an average price of $2.54 per share, for a total transaction of $508,000.00.
- On Friday, August 5th, Phillip Md Et Al Frost bought 350,000 shares of OPKO Health stock. The shares were acquired at an average price of $2.29 per share, for a total transaction of $801,500.00.
- On Tuesday, June 21st, Phillip Md Et Al Frost purchased 200,000 shares of OPKO Health stock. The stock was purchased at an average price of $2.39 per share, for a total transaction of $478,000.00.
- 8月17日，星期三，Phillip Md et Al Frost购买了20万股OPKO Health股票。这些股票是以每股2.54美元的平均价格收购的，总交易额为508,000.00美元。
- 8月5日，星期五，Phillip Md et Al Frost购买了35万股OPKO Health股票。这些股票是以每股2.29美元的平均价格收购的，总交易额为801,500.00美元。
- 6月21日，星期二，Phillip Md et Al Frost购买了20万股OPKO Health股票。股票是以每股2.39美元的平均价格购买的，总交易额为478,000.00美元。
OPKO Health Price Performance
Opko健康性价比
NASDAQ:OPK opened at $2.05 on Friday. The firm has a market cap of $1.58 billion, a PE ratio of -7.07 and a beta of 1.75. OPKO Health, Inc. has a 12 month low of $1.96 and a 12 month high of $5.25. The company has a quick ratio of 1.91, a current ratio of 2.30 and a debt-to-equity ratio of 0.12. The company's 50-day moving average price is $2.42 and its two-hundred day moving average price is $2.81.
纳斯达克：OPK上周五开盘报2.05美元。该公司的市值为15.8亿美元，市盈率为-7.07倍，贝塔系数为1.75。Opko Health，Inc.的12个月低点为1.96美元，12个月高位为5.25美元。该公司的速动比率为1.91，流动比率为2.30，债务权益比率为0.12。该公司的50日移动均线价格为2.42美元，200日移动均线价格为2.81美元。
Wall Street Analyst Weigh In
华尔街分析师也加入进来
Separately, Piper Sandler reduced their price target on shares of OPKO Health from $5.00 to $4.00 and set an "overweight" rating on the stock in a research report on Friday, August 5th.
另外，派珀·桑德勒将OPKO Health的股票目标价从5.00美元下调至4.00美元，并在8月5日星期五的一份研究报告中对该股设定了“增持”评级。
Hedge Funds Weigh In On OPKO Health
对冲基金对OPKO健康的看法
Large investors have recently modified their holdings of the stock. Swiss National Bank lifted its position in shares of OPKO Health by 7.5% during the first quarter. Swiss National Bank now owns 1,047,200 shares of the biotechnology company's stock worth $3,602,000 after purchasing an additional 72,900 shares in the last quarter. BNP Paribas Arbitrage SA lifted its position in shares of OPKO Health by 19.2% during the fourth quarter. BNP Paribas Arbitrage SA now owns 165,928 shares of the biotechnology company's stock worth $798,000 after purchasing an additional 26,707 shares in the last quarter. Columbia Asset Management acquired a new position in shares of OPKO Health during the fourth quarter worth approximately $67,000. E Fund Management Co. Ltd. lifted its position in shares of OPKO Health by 190.1% during the first quarter. E Fund Management Co. Ltd. now owns 81,338 shares of the biotechnology company's stock worth $280,000 after purchasing an additional 53,299 shares in the last quarter. Finally, Levin Capital Strategies L.P. acquired a new position in shares of OPKO Health during the first quarter worth approximately $52,000. 27.83% of the stock is currently owned by institutional investors and hedge funds.
大型投资者最近调整了对该股的持有量。瑞士国家银行在第一季度将其在OPKO Health的股票头寸提高了7.5%。瑞士国家银行目前持有这家生物技术公司的1,047,200股股票，价值3,602,000美元，上个季度又购买了72,900股。法国巴黎银行套利公司在第四季度将其在OPKO Health股票的头寸提高了19.2%。法国巴黎银行套利公司现在持有这家生物技术公司的165,928股股票，价值79.8万美元，上个季度又购买了26,707股。哥伦比亚资产管理公司在第四季度收购了OPKO Health的新头寸，价值约6.7万美元。易方达基金管理有限公司在第一季度将其在OPKO Health的股票头寸提高了190.1%。E Fund Management Co.Ltd.在上个季度增购了53,299股后，现在持有这家生物技术公司81,338股股票，价值28万美元。最后，Levin Capital Strategy L.P.在第一季度收购了OPKO Health公司价值约5.2万美元的新头寸。该公司27.83%的股票目前由机构投资者和对冲基金持有。
OPKO Health Company Profile
Opko Health公司简介
(Get Rating)
(获取评级)
OPKO Health, Inc, a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units; and a novel diagnostic instrument system to provide blood test results in the point-of-care setting, as well as 4Kscore prostate cancer testing services.
Opko Health，Inc.是一家医疗保健公司，在美国、爱尔兰、智利、西班牙、以色列、墨西哥和国际上从事诊断和制药业务。该公司的诊断部门经营着BioReference实验室，该实验室为疾病的检测、诊断、评估、监测和治疗提供实验室测试服务，包括深奥测试、分子诊断、解剖病理学、遗传学、妇女健康以及为医生办公室、诊所、医院、雇主和政府单位提供的矫正保健；以及在护理地点提供血液测试结果的新型诊断仪器系统，以及4KScore前列腺癌测试服务。
Featured Stories
专题报道
- Get a free copy of the StockNews.com research report on OPKO Health (OPK)
- 3 Banks Worth Considering For Q4
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- MarketBeat: Week in Review 9/12 – 9/16
- Is There a Cure for What is Ailing Teladoc Stock?
- No One Told These 3 Stocks It's a Down Week
- 免费获取StockNews.com关于OPKO健康的研究报告(OPK)
- 第四季度值得考虑的3家银行
- 股市：红海中的三座强国
- MarketBeat：回顾一周9/12-9/16
- 有什么办法可以治愈Teladoc股票的问题吗？
- 没有人告诉这三只股票这是下跌的一周
Receive News & Ratings for OPKO Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OPKO Health and related companies with MarketBeat.com's FREE daily email newsletter.
接受OPKO健康日报的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对OPKO Health和相关公司的最新新闻和分析师评级的每日简要摘要。